glp-1 secretion mechanism Frontiers GLP-1-based therapies for type 2
Description
Alexiades M, Palm MD, Kaufman-Janette J, et al
Heres what to keep in mind: No real GLP-1 drugs inside
Liraglutide, a GLP-1RA, has been shown to significantly reduce HbA1c, body weight, and systolic blood pressure (SBP) in patients with Type 2 DM and CKD, leading to a reduction in albuminuria [99]
The report showed that participants receiving the highest dose lost an average of 28.3% of body weight over 80 weeks
Don't just sell people whiskey, sell them something rare
